Toggle navigation
About
Abstract
Editorial Board
Publication Schedule
Subscription & Newsletter
Contact
Issue
23-3
Table of Contents
Editors Selection
Glaucoma Dialogue
Glaucoma Opinion
Abstracts
Abstracts
Abstracted Journals
Classification List
Index of Authors
Search
Home
Abstracts
Index of Authors
Author #29769
advertisement
Sun XH
23
Showing records 1 to 23 |
Display all abstracts from
Sun XH
106665
EphA4/ephrinA3 reverse signaling induced Müller cell gliosis and production of pro-inflammatory cytokines in experimental glaucoma
Xu LJ
Brain Research
2023; 1801: 148204
106290
Strengthening the clinical research of minimally invasive glaucoma surgery
Chen JY
Chinese Journal of Ophthalmology
2022; 58: 863-867
106595
The study of the correlation between age and the pathogenic factors of primary glaucoma: a review
Tan C
Chinese Journal of Ophthalmology
2022; 58: 1106-1110
106854
Safety profile of 0.0015% tafluprost eye drops in China: a post-marketing observational study
Chen XL; Fu YJ
International Journal of Ophthalmology
2023; 16: 108-114
106595
The study of the correlation between age and the pathogenic factors of primary glaucoma: a review
Hou Y
Chinese Journal of Ophthalmology
2022; 58: 1106-1110
106290
Strengthening the clinical research of minimally invasive glaucoma surgery
Sun XH
Chinese Journal of Ophthalmology
2022; 58: 863-867
106665
EphA4/ephrinA3 reverse signaling induced Müller cell gliosis and production of pro-inflammatory cytokines in experimental glaucoma
Wang HN
Brain Research
2023; 1801: 148204
106595
The study of the correlation between age and the pathogenic factors of primary glaucoma: a review
Qiao YS
Chinese Journal of Ophthalmology
2022; 58: 1106-1110
106854
Safety profile of 0.0015% tafluprost eye drops in China: a post-marketing observational study
Qu B
International Journal of Ophthalmology
2023; 16: 108-114
106665
EphA4/ephrinA3 reverse signaling induced Müller cell gliosis and production of pro-inflammatory cytokines in experimental glaucoma
Zhou H; Li SY
Brain Research
2023; 1801: 148204
106854
Safety profile of 0.0015% tafluprost eye drops in China: a post-marketing observational study
Wang YW
International Journal of Ophthalmology
2023; 16: 108-114
106595
The study of the correlation between age and the pathogenic factors of primary glaucoma: a review
Chen JY
Chinese Journal of Ophthalmology
2022; 58: 1106-1110
106665
EphA4/ephrinA3 reverse signaling induced Müller cell gliosis and production of pro-inflammatory cytokines in experimental glaucoma
Li F
Brain Research
2023; 1801: 148204
106595
The study of the correlation between age and the pathogenic factors of primary glaucoma: a review
Sun XH
Chinese Journal of Ophthalmology
2022; 58: 1106-1110
106854
Safety profile of 0.0015% tafluprost eye drops in China: a post-marketing observational study
Tang X; Wang YH
International Journal of Ophthalmology
2023; 16: 108-114
106665
EphA4/ephrinA3 reverse signaling induced Müller cell gliosis and production of pro-inflammatory cytokines in experimental glaucoma
Miao Y
Brain Research
2023; 1801: 148204
106854
Safety profile of 0.0015% tafluprost eye drops in China: a post-marketing observational study
Zhou GY
International Journal of Ophthalmology
2023; 16: 108-114
106665
EphA4/ephrinA3 reverse signaling induced Müller cell gliosis and production of pro-inflammatory cytokines in experimental glaucoma
Lei B; Sun XH
Brain Research
2023; 1801: 148204
106854
Safety profile of 0.0015% tafluprost eye drops in China: a post-marketing observational study
Lin MK
International Journal of Ophthalmology
2023; 16: 108-114
106665
EphA4/ephrinA3 reverse signaling induced Müller cell gliosis and production of pro-inflammatory cytokines in experimental glaucoma
Gao F
Brain Research
2023; 1801: 148204
106854
Safety profile of 0.0015% tafluprost eye drops in China: a post-marketing observational study
Shen JY
International Journal of Ophthalmology
2023; 16: 108-114
106665
EphA4/ephrinA3 reverse signaling induced Müller cell gliosis and production of pro-inflammatory cytokines in experimental glaucoma
Wang Z
Brain Research
2023; 1801: 148204
106854
Safety profile of 0.0015% tafluprost eye drops in China: a post-marketing observational study
Yao J; Li SY; Wu MQ; Peng HZ; Lai MY; Wu RY; Zhang YN; Li Y; Wu XJ; Zhang MC; Guo SP; Sun XH
International Journal of Ophthalmology
2023; 16: 108-114
Issue
23-3
Table of Contents
Editor's Selection
PDF
EPUB
Change Issue
24-4
24-3
24-1/2
23-4
23-3
23-2
23-1
22-4
22-3
22-2
22-1
21-4
21-3
21-2
21-1
20-4
20-3
20-2
20-1
19-4
19-3
19-2
19-1
18-4
18-3
18-2
18-1
17-4
17-3
17-2
17-1
16-4
16-3
16-2
16-1
15-4
15-3
15-2
15-1
14-4
14-3
14-2
14-1
13-4
13-3
13-2
13-1
12-4
12-3
12-2
12-1
11-4
11-3
11-2
11-1
10-4
10-3
10-2
10-1
9-4
9-3
9-2
9-1
8-4
8-3
8-2
8-1
7-3
7-2
7-1
6-3
6-2
6-1
5-3
5-2
5-1
4-3
4-2
4-1
3-3
3-2
3-1
2-3
2-2
2-1
1-3
1-2
1-1
advertisement